Document quand l'auteur est "Labrie, Marilyne"

Centre INRS-Institut Armand Frappier

Lee, Jinho; Labrie, Marilyne; Yong, Gen; Camp, Todd; Ma, Hongli; Grout, Megan; Xu, Wei; Beasley, Georgia; Schuchter, Lynn Mara; McGettigan, Suzanne; O'Rourke, Donald M; Herlyn, Meenhard; Corless, Christopher L; Mills, Gordon B et Zhang, Gao (2020). Multiomics profiling of longitudinal melanoma specimens unravels molecular mechanisms of resistance to sequential targeted and cancer immunotherapies In: Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), May 29-31, 2020, virtuel.

Labrie, Marilyne (2016). Expression et fonctions des galectines dans le cancer Thèse. Québec, Université du Québec, Institut National de la Recherche Scientifique, Doctorat en virologie et immunologie, 213 p.

Grosset, Andrée-Anne; Labrie, Marilyne; Vladoiu, Maria Claudia; Yousef, Einas M; Gaboury, Louis et St-Pierre, Yves (2016). Galectin signatures contribute to the heterogeneity of breast cancer and provide new prognostic information and therapeutic targets Oncotarget , vol. 7 , nº 14. pp. 18183-18203. DOI: 10.18632/oncotarget.7784.

Labrie, Marilyne; Vladoiu, Maria Claudia; Leclerc, Bruno G; Grosset, Andrée-Anne; Gaboury, Louis; Stagg, John et St-Pierre, Yves (2015). A Mutation in the Carbohydrate Recognition Domain Drives a Phenotypic Switch in the Role of Galectin-7 in Prostate Cancer PLoS ONE , vol. 10 , nº 7. e0131307. DOI: 10.1371/journal.pone.0131307.

Vladoiu, Maria Claudia; Labrie, Marilyne; Létourneau, Myriam; Egesborg, Philippe; Gagné, Donald; Billard, Étienne; Grosset, Andrée-Anne; Doucet, Nicolas ORCID: https://orcid.org/0000-0002-1952-9380; Chatenet, David et St-Pierre, Yves (2015). Design of a peptidic inhibitor that targets the dimer interface of a prototypic galectin Oncotarget , vol. 6 , nº 38. pp. 40970-80. DOI: 10.18632/oncotarget.5403.

Grosset, Andrée-Anne; Labrie, Marilyne; Gagné, Donald; Vladoiu, Maria Claudia; Gaboury, Louis; Doucet, Nicolas et St-Pierre, Yves (2014). Cytosolic galectin-7 impairs p53 functions and induces chemoresistance in breast cancer cells BMC Cancer , vol. 14 . p. 801. DOI: 10.1186/1471-2407-14-801.

Labrie, Marilyne; Vladoiu, Maria Claudia; Grosset, Andrée-Anne; Gaboury, Louis et St-Pierre, Yves (2014). Expression and functions of galectin-7 in ovarian cancer Oncotarget , vol. 5 , nº 17. pp. 7705-7721. DOI: 10.18632/oncotarget.2299.

Vladoiu, Maria Claudia; Labrie, Marilyne et St-Pierre, Yves (2014). Intracellular galectins in cancer cells: Potential new targets for therapy (Review) International Journal of Oncology , vol. 44 , nº 4. pp. 1001-14. DOI: 10.3892/ijo.2014.2267.

Campion, Carole G.; Labrie, Marilyne; Grosset, Andrée-Anne et St-Pierre, Yves (2014). The CCAAT/Enhancer-Binding Protein Beta-2 Isoform (CEBPbeta-2) Upregulates Galectin-7 Expression in Human Breast Cancer Cells PLoS ONE , vol. 9 , nº 5. e95087. DOI: 10.1371/journal.pone.0095087.

Labrie, Marilyne et St-Pierre, Yves (2013). Epigenetic regulation of mmp-9 gene expression Cellular and Molecular Life Sciences , vol. 70 , nº 17. pp. 3109-3124. DOI: 10.1007/s00018-012-1214-z.

Campion, Carole G.; Labrie, Marilyne; Lavoie, Geneviève et St-Pierre, Yves (2013). Expression of Galectin-7 Is Induced in Breast Cancer Cells by Mutant p53 PLoS ONE , vol. 8 , nº 8. e72468. DOI: 10.1371/journal.pone.0072468.

Labrie, Marilyne; Communal, Laudine et St-Pierre, Yves . Les galectines comme biomarqueurs dans le cancer de l’ovaire In: 12ème colloque du centre de recherche Biomed, 5 mai 2016, Centre de congrès Palace, Laval (Québec).

Labrie, Marilyne; Grosset, Andrée-Anne; Vladoiu, Maria Claudia; Gaboury, Louis et St-Pierre, Yves . Rôle anti-tumoral de la galectine-7 dans le cancer de la prostate In: 8e édition, Congrès Armand-Frappier 2013, 14-16 novembre 2013, Orford (Québec).